 | • レポートコード：MRC2012B1175 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、呼吸窮迫症候群の世界市場を広く調査・分析し、今後の市場展望をまとめております。呼吸窮迫症候群の種類別市場規模（ポーラクタントアルファ、ベラクタント、カルファクタント、その他）、用途別市場規模（初期早産児、中期～後期早産児、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Chiesi Farmaceutici、AbbVie、CR-Double Crane、Noargen、ONY Biotech、JW Pharmaceuticals、Yuhan Corporation、 ・地域別グローバル市場分析 2015年-2020年 ・呼吸窮迫症候群の北米市場（アメリカ、カナダ、メキシコ） ・呼吸窮迫症候群のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・呼吸窮迫症候群のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・呼吸窮迫症候群の南米市場（ブラジル、アルゼンチン） ・呼吸窮迫症候群の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ポーラクタントアルファ、ベラクタント、カルファクタント、その他 ・用途別分析：初期早産児、中期～後期早産児、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Respiratory Distress Syndrome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Respiratory Distress Syndrome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 468.9 million by 2025, from USD 381.9 million in 2019.
Market segmentation
Respiratory Distress Syndrome market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Respiratory Distress Syndrome market has been segmented into:
Poractant Alfa
Beractant
Calfactant
Others
By Application, Respiratory Distress Syndrome has been segmented into:
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Respiratory Distress Syndrome market presented in the report. This section sheds light on the sales growth of different regional and country-level Respiratory Distress Syndrome markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Respiratory Distress Syndrome market.
The report offers in-depth assessment of the growth and other aspects of the Respiratory Distress Syndrome market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Respiratory Distress Syndrome Market Share Analysis
Respiratory Distress Syndrome competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Respiratory Distress Syndrome sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Respiratory Distress Syndrome sales, revenue and market share for each player covered in this report.
The major players covered in Respiratory Distress Syndrome are:
Chiesi Farmaceutici
AbbVie
CR-Double Crane
Noargen
ONY Biotech
JW Pharmaceuticals
Yuhan Corporation
Among other players domestic and global, Respiratory Distress Syndrome market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Respiratory Distress Syndrome Market Overview
1.1 Product Overview and Scope of Respiratory Distress Syndrome
1.2 Classification of Respiratory Distress Syndrome by Type
1.2.1 Global Respiratory Distress Syndrome Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Respiratory Distress Syndrome Revenue Market Share by Type in 2019
1.2.3 Poractant Alfa
1.2.4 Beractant
1.2.5 Calfactant
1.2.6 Others
1.3 Global Respiratory Distress Syndrome Market by Application
1.3.1 Overview: Global Respiratory Distress Syndrome Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Global Respiratory Distress Syndrome Market by Regions
1.4.1 Global Respiratory Distress Syndrome Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Respiratory Distress Syndrome (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Respiratory Distress Syndrome Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Respiratory Distress Syndrome Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Respiratory Distress Syndrome Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Respiratory Distress Syndrome Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Respiratory Distress Syndrome Status and Prospect (2015-2025)
2 Company Profiles
2.1 Chiesi Farmaceutici
2.1.1 Chiesi Farmaceutici Details
2.1.2 Chiesi Farmaceutici Major Business
2.1.3 Chiesi Farmaceutici SWOT Analysis
2.1.4 Chiesi Farmaceutici Product and Services
2.1.5 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie SWOT Analysis
2.2.4 AbbVie Product and Services
2.2.5 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.3 CR-Double Crane
2.3.1 CR-Double Crane Details
2.3.2 CR-Double Crane Major Business
2.3.3 CR-Double Crane SWOT Analysis
2.3.4 CR-Double Crane Product and Services
2.3.5 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.4 Noargen
2.4.1 Noargen Details
2.4.2 Noargen Major Business
2.4.3 Noargen SWOT Analysis
2.4.4 Noargen Product and Services
2.4.5 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.5 ONY Biotech
2.5.1 ONY Biotech Details
2.5.2 ONY Biotech Major Business
2.5.3 ONY Biotech SWOT Analysis
2.5.4 ONY Biotech Product and Services
2.5.5 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.6 JW Pharmaceuticals
2.6.1 JW Pharmaceuticals Details
2.6.2 JW Pharmaceuticals Major Business
2.6.3 JW Pharmaceuticals Product and Services
2.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.7 Yuhan Corporation
2.7.1 Yuhan Corporation Details
2.7.2 Yuhan Corporation Major Business
2.7.3 Yuhan Corporation Product and Services
2.7.4 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Respiratory Distress Syndrome Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Respiratory Distress Syndrome Players Market Share
3.2.2 Top 10 Respiratory Distress Syndrome Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Respiratory Distress Syndrome Revenue and Market Share by Regions
4.2 North America Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
4.3 Europe Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
4.5 South America Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
5 North America Respiratory Distress Syndrome Revenue by Countries
5.1 North America Respiratory Distress Syndrome Revenue by Countries (2015-2020)
5.2 USA Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
5.3 Canada Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
5.4 Mexico Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
6 Europe Respiratory Distress Syndrome Revenue by Countries
6.1 Europe Respiratory Distress Syndrome Revenue by Countries (2015-2020)
6.2 Germany Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
6.3 UK Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
6.4 France Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
6.5 Russia Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
6.6 Italy Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Respiratory Distress Syndrome Revenue by Countries
7.1 Asia-Pacific Respiratory Distress Syndrome Revenue by Countries (2015-2020)
7.2 China Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
7.3 Japan Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
7.4 Korea Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
7.5 India Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
8 South America Respiratory Distress Syndrome Revenue by Countries
8.1 South America Respiratory Distress Syndrome Revenue by Countries (2015-2020)
8.2 Brazil Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
8.3 Argentina Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Respiratory Distress Syndrome by Countries
9.1 Middle East & Africa Respiratory Distress Syndrome Revenue by Countries (2015-2020)
9.2 Saudi Arabia Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
9.3 UAE Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
9.4 Egypt Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
9.5 South Africa Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Respiratory Distress Syndrome Revenue and Market Share by Type (2015-2020)
10.2 Global Respiratory Distress Syndrome Market Forecast by Type (2019-2024)
10.3 Poractant Alfa Revenue Growth Rate (2015-2025)
10.4 Beractant Revenue Growth Rate (2015-2025)
10.5 Calfactant Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Respiratory Distress Syndrome Market Segment by Application
11.1 Global Respiratory Distress Syndrome Revenue Market Share by Application (2015-2020)
11.2 Respiratory Distress Syndrome Market Forecast by Application (2019-2024)
11.3 Very Preterm Infants Revenue Growth (2015-2020)
11.4 Moderate to Late Preterm Infants Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Respiratory Distress Syndrome Market Size Forecast (2021-2025)
12.1 Global Respiratory Distress Syndrome Market Size Forecast (2021-2025)
12.2 Global Respiratory Distress Syndrome Market Forecast by Regions (2021-2025)
12.3 North America Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
12.4 Europe Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
12.6 South America Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Respiratory Distress Syndrome Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Respiratory Distress Syndrome by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Respiratory Distress Syndrome Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Respiratory Distress Syndrome Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Respiratory Distress Syndrome Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Chiesi Farmaceutici Corporate Information, Location and Competitors
Table 7. Chiesi Farmaceutici Respiratory Distress Syndrome Major Business
Table 8. Chiesi Farmaceutici Respiratory Distress Syndrome Total Revenue (USD Million) (2017-2018)
Table 9. Chiesi Farmaceutici SWOT Analysis
Table 10. Chiesi Farmaceutici Respiratory Distress Syndrome Product and Solutions
Table 11. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. AbbVie Corporate Information, Location and Competitors
Table 13. AbbVie Respiratory Distress Syndrome Major Business
Table 14. AbbVie Respiratory Distress Syndrome Total Revenue (USD Million) (2018-2019)
Table 15. AbbVie SWOT Analysis
Table 16. AbbVie Respiratory Distress Syndrome Product and Solutions
Table 17. AbbVie Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. CR-Double Crane Corporate Information, Location and Competitors
Table 19. CR-Double Crane Respiratory Distress Syndrome Major Business
Table 20. CR-Double Crane Respiratory Distress Syndrome Total Revenue (USD Million) (2017-2018)
Table 21. CR-Double Crane SWOT Analysis
Table 22. CR-Double Crane Respiratory Distress Syndrome Product and Solutions
Table 23. CR-Double Crane Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Noargen Corporate Information, Location and Competitors
Table 25. Noargen Respiratory Distress Syndrome Major Business
Table 26. Noargen Respiratory Distress Syndrome Total Revenue (USD Million) (2017-2018)
Table 27. Noargen SWOT Analysis
Table 28. Noargen Respiratory Distress Syndrome Product and Solutions
Table 29. Noargen Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. ONY Biotech Corporate Information, Location and Competitors
Table 31. ONY Biotech Respiratory Distress Syndrome Major Business
Table 32. ONY Biotech Respiratory Distress Syndrome Total Revenue (USD Million) (2017-2018)
Table 33. ONY Biotech SWOT Analysis
Table 34. ONY Biotech Respiratory Distress Syndrome Product and Solutions
Table 35. ONY Biotech Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. JW Pharmaceuticals Corporate Information, Location and Competitors
Table 37. JW Pharmaceuticals Respiratory Distress Syndrome Major Business
Table 38. JW Pharmaceuticals Respiratory Distress Syndrome Total Revenue (USD Million) (2017-2018)
Table 39. JW Pharmaceuticals SWOT Analysis
Table 40. JW Pharmaceuticals Respiratory Distress Syndrome Product and Solutions
Table 41. JW Pharmaceuticals Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Yuhan Corporation Corporate Information, Location and Competitors
Table 43. Yuhan Corporation Respiratory Distress Syndrome Major Business
Table 44. Yuhan Corporation Respiratory Distress Syndrome Total Revenue (USD Million) (2017-2018)
Table 45. Yuhan Corporation SWOT Analysis
Table 46. Yuhan Corporation Respiratory Distress Syndrome Product and Solutions
Table 47. Yuhan Corporation Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global Respiratory Distress Syndrome Revenue (Million USD) by Players (2015-2020)
Table 49. Global Respiratory Distress Syndrome Revenue Share by Players (2015-2020)
Table 50. Global Respiratory Distress Syndrome Revenue (Million USD) by Regions (2015-2020)
Table 51. Global Respiratory Distress Syndrome Revenue Market Share by Regions (2015-2020)
Table 52. North America Respiratory Distress Syndrome Revenue by Countries (2015-2020)
Table 53. North America Respiratory Distress Syndrome Revenue Market Share by Countries (2015-2020)
Table 54. Europe Respiratory Distress Syndrome Revenue (Million USD) by Countries (2015-2020)
Table 55. Asia-Pacific Respiratory Distress Syndrome Revenue (Million USD) by Countries (2015-2020)
Table 56. South America Respiratory Distress Syndrome Revenue by Countries (2015-2020)
Table 57. South America Respiratory Distress Syndrome Revenue Market Share by Countries (2015-2020)
Table 58. Middle East and Africa Respiratory Distress Syndrome Revenue (Million USD) by Countries (2015-2020)
Table 59. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Countries (2015-2020)
Table 60. Global Respiratory Distress Syndrome Revenue (Million USD) by Type (2015-2020)
Table 61. Global Respiratory Distress Syndrome Revenue Share by Type (2015-2020)
Table 62. Global Respiratory Distress Syndrome Revenue Forecast by Type (2021-2025)
Table 63. Global Respiratory Distress Syndrome Revenue by Application (2015-2020)
Table 64. Global Respiratory Distress Syndrome Revenue Share by Application (2015-2020)
Table 65. Global Respiratory Distress Syndrome Revenue Forecast by Application (2021-2025)
Table 66. Global Respiratory Distress Syndrome Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Respiratory Distress Syndrome Picture
Figure 2. Global Respiratory Distress Syndrome Revenue Market Share by Type in 2019
Figure 3. Poractant Alfa Picture
Figure 4. Beractant Picture
Figure 5. Calfactant Picture
Figure 6. Others Picture
Figure 7. Respiratory Distress Syndrome Revenue Market Share by Application in 2019
Figure 8. Very Preterm Infants Picture
Figure 9. Moderate to Late Preterm Infants Picture
Figure 10. Others Picture
Figure 11. Global Respiratory Distress Syndrome Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Respiratory Distress Syndrome Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Respiratory Distress Syndrome Revenue Market Share in 2019
Figure 20. Global Top 10 Players Respiratory Distress Syndrome Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Respiratory Distress Syndrome Revenue Market Share by Regions (2015-2020)
Figure 24. Global Respiratory Distress Syndrome Revenue Market Share by Regions in 2018
Figure 25. North America Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 26. Europe Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 28. South America Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 30. North America Respiratory Distress Syndrome Revenue Market Share by Countries (2015-2020)
Figure 31. North America Respiratory Distress Syndrome Revenue Market Share by Countries in 2019
Figure 32. USA Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 33. Canada Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 35. Europe Respiratory Distress Syndrome Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Respiratory Distress Syndrome Revenue Market Share by Countries in 2019
Figure 37. Germany Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 38. UK Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 39. France Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 40. Russia Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 41. Italy Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Countries in 2019
Figure 44. China Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 45. Japan Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 46. Korea Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 47. India Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 49. South America Respiratory Distress Syndrome Revenue Market Share by Countries (2015-2020)
Figure 50. South America Respiratory Distress Syndrome Revenue Market Share by Countries in 2019
Figure 51. Brazil Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 56. UAE Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Respiratory Distress Syndrome Revenue and Growth Rate (2015-2020)
Figure 59. Global Respiratory Distress Syndrome Revenue Share by Type (2015-2020)
Figure 60. Global Respiratory Distress Syndrome Revenue Share by Type in 2019
Figure 61. Global Respiratory Distress Syndrome Market Share Forecast by Type (2021-2025)
Figure 62. Global Poractant Alfa Revenue Growth Rate (2015-2020)
Figure 63. Global Beractant Revenue Growth Rate (2015-2020)
Figure 64. Global Calfactant Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Respiratory Distress Syndrome Revenue Share by Application (2015-2020)
Figure 67. Global Respiratory Distress Syndrome Revenue Share by Application in 2019
Figure 68. Global Respiratory Distress Syndrome Market Share Forecast by Application (2021-2025)
Figure 69. Global Very Preterm Infants Revenue Growth Rate (2015-2020)
Figure 70. Global Moderate to Late Preterm Infants Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Respiratory Distress Syndrome Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Respiratory Distress Syndrome Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
Figure 76. Europe Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
Figure 78. South America Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Respiratory Distress Syndrome Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
消化器疾患治療 の世界市場（～2026年） Digestive distress treatment comprises of the treatment of liver and digestive tract diseases this comprises of stomach, gallbladder, pancreas, colon, duodenum, biliary tract, small intestine, and others. According to the study conducted by Scleroderma Foundation in 2014, after skin, the digestive s…- ブタ生殖＆呼吸器症候群ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Swine Reproductive and Respiratory Syndrome Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market play…
- 豚繁殖呼吸器症候群（PRRS）ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million …
- 下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…
- 呼吸器疾患用吸入器の世界市場（～2026年） Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. …